These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
92 related articles for article (PubMed ID: 2511259)
1. [Galactosyltransferase isozyme II (GT-II) as a new tumor marker for ovarian cancers--especially for clear cell carcinoma]. Nozawa S; Kiguchi K; Yajima M; Udagawa Y; Sakuma T; Iizuka R; Narisawa S; Sakayori M Nihon Sanka Fujinka Gakkai Zasshi; 1989 Sep; 41(9):1341-7. PubMed ID: 2511259 [TBL] [Abstract][Full Text] [Related]
2. [The usefulness and limitation of sugar antigen in ovarian cancers--with special reference to a new tumor marker, CA54/61]. Nozawa S Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-1):1147-51. PubMed ID: 2499263 [TBL] [Abstract][Full Text] [Related]
3. Characterization and immunoassay of human tumor-associated galactosyltransferase isoenzyme II. Uemura M; Winant RC; Sikic BI; Brandt AE Cancer Res; 1988 Sep; 48(18):5325-34. PubMed ID: 3136919 [TBL] [Abstract][Full Text] [Related]
4. Cancer-associated galactosyltransferase as a new tumor marker for ovarian clear cell carcinoma. Nozawa S; Yajima M; Sakuma T; Udagawa Y; Kiguchi K; Sakayori M; Narisawa S; Iizuka R; Uemura M Cancer Res; 1990 Feb; 50(3):754-9. PubMed ID: 2105162 [TBL] [Abstract][Full Text] [Related]
5. [On the clinical usefulness of a few sugar antigens and a galactosyl-transferase]. Nozawa S; Izumi S; Sakayori M; Narisawa S; Kojima K; Iizuka R; Iwamori M; Nagai Y Hum Cell; 1988 Mar; 1(1):37-45. PubMed ID: 3155288 [TBL] [Abstract][Full Text] [Related]
6. Immunoassay of serum galactosyltransferase isoenzyme II in cancer patients and control subjects. Uemura M; Winant RC; Brandt AE Cancer Res; 1988 Sep; 48(18):5335-41. PubMed ID: 3136920 [TBL] [Abstract][Full Text] [Related]
7. [Preclinical and clinical studies on a tumor marker, galactosyltransferase associated with tumor (GAT), in ovarian cancer (second report)--clinical significance of GAT and comparison with other tumor markers]. Nozawa S; Udagawa Y; Ito K; Susumu N; Sasaki H; Aoki D Gan To Kagaku Ryoho; 1993 Feb; 20(2):279-85. PubMed ID: 8434967 [TBL] [Abstract][Full Text] [Related]
8. Mouse monoclonal antibodies which recognize a human (beta 1-4)galactosyl-transferase associated with tumor in body fluids. Uemura M; Sakaguchi T; Uejima T; Nozawa S; Narimatsu H Cancer Res; 1992 Nov; 52(22):6153-7. PubMed ID: 1423258 [TBL] [Abstract][Full Text] [Related]
9. Galactosyltransferase associated with tumor in patients with ovarian cancer: factors involved in elevation of serum galactosyltransferase. Saitoh E; Aoki D; Susumu N; Udagawa Y; Nozawa S Int J Oncol; 2003 Aug; 23(2):303-10. PubMed ID: 12851678 [TBL] [Abstract][Full Text] [Related]
10. Uridine 5'-diphosphate-galactose:glycoprotein galactosyltransferase activity in the ovarian cancer patient. Bhattacharya M; Chatterjee SK; Barlow JJ Cancer Res; 1976 Jun; 36(6):2096-101. PubMed ID: 57828 [TBL] [Abstract][Full Text] [Related]
11. [Applications of tumor markers to the screening of endometrial and ovarian cancers]. Nozawa S; Takamatsu K; Tsukazaki K; Udagawa Y Nihon Rinsho; 1996 Jun; 54(6):1665-73. PubMed ID: 8691627 [TBL] [Abstract][Full Text] [Related]
12. [Application of monoclonal antibody OC 125 in gynecological oncology]. Wu AR; Wang EY; Wang XX; Jia XH; Li L Zhonghua Zhong Liu Za Zhi; 1988 Mar; 10(2):132-6. PubMed ID: 3208653 [TBL] [Abstract][Full Text] [Related]
13. [Clinical significance of galactosyltransferase associated with tumor (GAT), a new tumor marker for ovarian cancer--with special reference to the discrimination between ovarian cancer and endometriosis]. Nozawa S; Udagawa Y; Ito K; Nishimura H; Yakushiji M; Shiota M; Noda K; Yajima M; Ohkura H; Murae M Gan To Kagaku Ryoho; 1994 Mar; 21(4):507-16. PubMed ID: 8129392 [TBL] [Abstract][Full Text] [Related]
14. Elevation of 4 beta-galactosyltransferase activity for paragloboside synthesis in sera of patients with cancer. Nishiwaki S; Taki T; Handa N; Hattori N; Takeshita K; Endo M; Handa S Cancer Res; 1992 Apr; 52(7):1875-80. PubMed ID: 1551117 [TBL] [Abstract][Full Text] [Related]
15. Murine monoclonal antibodies against galactosyltransferase from the ascites of ovarian cancer patients. Chatterjee SK; Bhattacharya M; Barlow JJ Cancer Res; 1984 Dec; 44(12 Pt 1):5725-32. PubMed ID: 6209001 [TBL] [Abstract][Full Text] [Related]
16. [Preparative isolation of human galactosyltransferase. A comparison of methods]. Mikhaĭlov AD; Zhordaniia KI Biokhimiia; 1990 Nov; 55(11):2103-7. PubMed ID: 2128192 [TBL] [Abstract][Full Text] [Related]
17. [Clinical usefulness of tumor markers for the diagnosis of ovarian cancer]. Ito K; Udagawa Y; Nozawa S Gan To Kagaku Ryoho; 1992 Oct; 19(12):1964-70. PubMed ID: 1417005 [TBL] [Abstract][Full Text] [Related]
18. Tissue polypeptide antigen, galactosyltransferase isoenzyme II and pancreatic oncofetal antigen serum determination: role in pancreatic cancer diagnosis. Basso D; Fabris C; Panucci A; Del Favero G; Angonese C; Plebani M; Petrin P; Burlina A; Naccarato R Int J Pancreatol; 1988; 3 Suppl 1():S95-100. PubMed ID: 3145303 [TBL] [Abstract][Full Text] [Related]
19. Critical comments on galactosyltransferase. Pohl AL Cancer Detect Prev; 1984; 7(4):299-310. PubMed ID: 6435872 [TBL] [Abstract][Full Text] [Related]
20. Clinical usefulness of sialyl SSEA-1 antigen as tumor marker for ovarian cancer as compared with CA125, CA19-9, TPA, IAP, CEA and ferritin. Yabushita H; Sawaguchi K; Hieda S; Ogawa A; Tomatsu A; Noguchi M; Ishihara M Nihon Sanka Fujinka Gakkai Zasshi; 1989 Feb; 41(2):217-24. PubMed ID: 2566639 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]